Mechanism of cytotoxicity of copper(I) complexes of 1,2-bis(diphenylphosphino)ethane
- PMID: 15715467
- DOI: 10.1021/jm049430g
Mechanism of cytotoxicity of copper(I) complexes of 1,2-bis(diphenylphosphino)ethane
Abstract
The cytotoxic properties of arylphosphines are regulated by metals. We have synthesized a series of copper(I) complexes of 1,2-bis(diphenylphosphino)ethane (DPPE) and tested their in vitro cytotoxicity in a human lung carcinoma cell line H460. One of the complexes [Cu(2)(DPPE)(3)(CH(3)CN)(2)](ClO(4))(2) (C1), showed maximum cytotoxicity comparable to that of adriamycin. Treatment of cells with C1 caused DNA damage in vitro and activated the p53 pathway. Flow cytometry revealed that growth inhibition by C1 was due to a combination of cell cycle arrest and apoptosis. Simultaneous addition of C1 and adriamycin increased the cytotoxicity of either compound, suggesting the potential use of adriamycin in combination with C1. DNA binding and simulation studies suggest that adriamycin binds to DNA synergistically in the presence of C1. Thus, we have identified C1, a copper(I) complex of DPPE, as a potential chemotherapeutic drug for further testing, which could be used either alone or in combination with other chemotherapeutic drugs.
Similar articles
-
Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.J Med Chem. 2006 Dec 14;49(25):7317-24. doi: 10.1021/jm0601248. J Med Chem. 2006. PMID: 17149861
-
New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity.J Inorg Biochem. 2006 Feb;100(2):299-304. doi: 10.1016/j.jinorgbio.2005.11.014. Epub 2006 Jan 4. J Inorg Biochem. 2006. PMID: 16387362
-
In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.Cancer Res. 1986 Nov;46(11):5486-93. Cancer Res. 1986. PMID: 3756897
-
Square-planar Pd(II), Pt(II), and Au(III) terpyridine complexes: their syntheses, physical properties, supramolecular constructs, and biomedical activities.Chem Rev. 2008 Jun;108(6):1834-95. doi: 10.1021/cr0781059. Chem Rev. 2008. PMID: 18543874 Review. No abstract available.
-
DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.Drug Resist Updat. 2006 Jun;9(3):111-22. doi: 10.1016/j.drup.2006.05.002. Epub 2006 Jun 21. Drug Resist Updat. 2006. PMID: 16790363 Review.
Cited by
-
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines.Invest New Drugs. 2011 Dec;29(6):1213-23. doi: 10.1007/s10637-010-9466-7. Epub 2010 Jun 22. Invest New Drugs. 2011. PMID: 20567997
-
Evaluation of anticancer activity in vitro of a stable copper(I) complex with phosphine-peptide conjugate.Sci Rep. 2021 Dec 14;11(1):23943. doi: 10.1038/s41598-021-03352-2. Sci Rep. 2021. PMID: 34907288 Free PMC article.
-
Platinum(II) chloride indenyl complexes: electrochemical and biological evaluation.J Biol Inorg Chem. 2011 Jun;16(5):695-713. doi: 10.1007/s00775-011-0771-1. Epub 2011 Mar 29. J Biol Inorg Chem. 2011. PMID: 21594772
-
SOD mimetic activity and antiproliferative properties of a novel tetra nuclear copper (II) complex.J Biol Inorg Chem. 2015 Dec;20(8):1287-98. doi: 10.1007/s00775-015-1307-x. Epub 2015 Nov 7. J Biol Inorg Chem. 2015. PMID: 26547749
-
The Anti-Breast Cancer Stem Cell Potency of Copper(I)-Non-Steroidal Anti-Inflammatory Drug Complexes.Molecules. 2023 Sep 1;28(17):6401. doi: 10.3390/molecules28176401. Molecules. 2023. PMID: 37687229 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous